Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for IQV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -381.00M
March 31, 2026 -196.00M
December 31, 2025 -1.104B
September 30, 2025 -550.00M
June 30, 2025 -346.00M
March 31, 2025 -305.00M
December 31, 2024 -310.00M
September 30, 2024 -599.00M
June 30, 2024 -221.00M
March 31, 2024 -314.00M
December 31, 2023 -212.00M
September 30, 2023 -573.00M
June 30, 2023 -596.00M
March 31, 2023 -222.00M
December 31, 2022 -477.00M
September 30, 2022 -717.00M
June 30, 2022 -199.00M
March 31, 2022 -613.00M
December 31, 2021 -647.00M
September 30, 2021 -1.097B
June 30, 2021 -941.00M
March 31, 2021 -176.00M
December 31, 2020 -236.00M
September 30, 2020 -191.00M
June 30, 2020 -219.00M
Date Value
March 31, 2020 -150.00M
December 31, 2019 -280.00M
September 30, 2019 -400.00M
June 30, 2019 -195.00M
March 31, 2019 -315.00M
December 31, 2018 -178.00M
September 30, 2018 -182.00M
June 30, 2018 -330.00M
March 31, 2018 -120.00M
December 31, 2017 -416.00M
September 30, 2017 -334.00M
June 30, 2017 -200.00M
March 31, 2017 -240.00M
December 31, 2016 1.813B
September 30, 2016 -22.29M
June 30, 2016 -16.08M
March 31, 2016 -43.47M
December 31, 2015 -27.55M
September 30, 2015 6.065M
June 30, 2015 -27.16M
March 31, 2015 -18.31M
December 31, 2014 -27.19M
September 30, 2014 -112.92M
June 30, 2014 -19.03M
March 31, 2014 -13.98M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. -23.88M
Charles River Laboratories International, Inc. 28.10M
Moderna, Inc. 329.00M
Fortrea Holdings, Inc. -7.00M
OmniAb, Inc. -7.622M